drugset / Trial / NCT02032836

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

NCT02032836

Phase 1/2 Completed 27 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

Administration of iloprost aerosol comparing two nebulizers: FOX and I-Neb

Timeline

Start
2014-03-10
Primary completion
2015-01-07
Completion
2017-09-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 1.25 ug Inhaled
Subject Iloprost Other / unclassified 2.5 ug Inhaled
Subject Iloprost Other / unclassified 5 ug Inhaled